Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H23N3O4.ClH |
| Molecular Weight | 369.843 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC1=CC=CC=C1OCC(O)CNCCN2C=C(C)C(=O)NC2=O
InChI
InChIKey=OOHOLIQGGQPTLN-UHFFFAOYSA-N
InChI=1S/C17H23N3O4.ClH/c1-12-5-3-4-6-15(12)24-11-14(21)9-18-7-8-20-10-13(2)16(22)19-17(20)23;/h3-6,10,14,18,21H,7-9,11H2,1-2H3,(H,19,22,23);1H
Primidolol (also known as UK-11,443) is an imidazolidinone derivative patented by American pharmaceutical corporation Pfizer Corp as a specific β-adrenergic blocker. In clinical trials, Primidolol shows some antihypertensive activity but the overall change in the cardiovascular parameters failed to demonstrate a significant difference compared to placebo.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
40778-40-3
Created by
admin on Mon Mar 31 22:12:23 GMT 2025 , Edited by admin on Mon Mar 31 22:12:23 GMT 2025
|
PRIMARY | |||
|
QAT67NBE8Q
Created by
admin on Mon Mar 31 22:12:23 GMT 2025 , Edited by admin on Mon Mar 31 22:12:23 GMT 2025
|
PRIMARY | |||
|
176173
Created by
admin on Mon Mar 31 22:12:23 GMT 2025 , Edited by admin on Mon Mar 31 22:12:23 GMT 2025
|
PRIMARY | |||
|
DTXSID4021187
Created by
admin on Mon Mar 31 22:12:23 GMT 2025 , Edited by admin on Mon Mar 31 22:12:23 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
